Atlas Trials

A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

Clinical trial NCT06004960 · COMPLETED

Trial details

NCT number
NCT06004960
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Start date
2014-10-20
Primary completion
2014-12-05
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.